
GC Pharma Announces Publication of Results From Phase III Clinical Trial of ‘GC5107’ Immune Globulin in Frontiers in Immunology
– The results of the trial demonstrate the efficacy, safety and tolerability of GC5107 in patients with PI YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today […]
